These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9272330)

  • 1. Pertussis: a worldwide problem.
    Ivanoff B; Robertson SE
    Dev Biol Stand; 1997; 89():3-13. PubMed ID: 9272330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can we control pertussis better? I. Changes in the epidemiology of pertussis].
    Gałazka A
    Przegl Epidemiol; 1997; 51(3):275-84. PubMed ID: 9411498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current epidemiology of pertussis in the United States.
    Hutchins SS; Cochi SL; Brink EW; Patriarca PA; Wassilak SG; Rovira EZ; Hinman AR
    Tokai J Exp Clin Med; 1988; 13 Suppl():103-9. PubMed ID: 2856218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of pertussis in industrialized countries].
    Baron S; Bégué P; Grimprel E
    Sante; 1994; 4(3):195-200. PubMed ID: 7921686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at pertussis immunization as it relates to current epidemiology and disease control.
    Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of children with diagnosed pertussis].
    Kardas-Sobantka D; Golebiowska M; Libich M; Stryjewska I
    Przegl Epidemiol; 2000; 54(3-4):357-65. PubMed ID: 11349599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis notifications in Australia, 1991 to 1997.
    Andrews R; Herceg A; Roberts C
    Commun Dis Intell; 1997 May; 21(11):145-8. PubMed ID: 9188218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children.
    Christie CD; Marx ML; Marchant CD; Reising SF
    N Engl J Med; 1994 Jul; 331(1):16-21. PubMed ID: 8202096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
    Li WC; Wu TZ; Huang YC; Huang LM
    Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis in Poland.
    Gzyl A; Augustynowicz E; Rabczenko D; Gniadek G; Slusarczyk J
    Int J Epidemiol; 2004 Apr; 33(2):358-65. PubMed ID: 15082640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of pertussis.
    Tan T; Trindade E; Skowronski D
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S10-8. PubMed ID: 15876918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.